Plain-English translation of NCT03010124 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a research study that collects biological samples—including tumor tissue, blood, fluid around the abdomen, and other samples—from ovarian cancer patients at different points during their care. Researchers will analyze these samples to identify genetic markers that help predict which patients will respond well to chemotherapy and which may develop resistance to treatment.
Some ovarian cancer patients respond well to chemotherapy while others develop resistance, and doctors don't yet have reliable ways to predict who will fall into which group. This study aims to discover genetic markers that could help personalize treatment decisions and improve outcomes for future patients.
You likely qualify if…
You likely don't qualify if…
If you join this study, researchers will collect samples from you at key points—such as at your initial diagnosis or when your cancer returns. These samples may include tumor tissue, blood, fluid from around your abdomen, and other biological materials. If your cancer returns and you have surgery or a biopsy, those samples will also be studied. Throughout your care, researchers will track how these genetic markers change and compare them to how your cancer responds to treatment.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
France